A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis
Clinical trial NCT06926582 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06926582
- Sponsor
- Hansoh BioMedical R&D Company
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-09
- Primary completion
- 2026-07-09
- Enrollment
- 305
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.